- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Undervalued Small Caps
Swiss Pharmaceuticals & Biotech Undervalued Small Caps
Results
2
0 new
Undervalued Small Caps
2 companies
Cosmo Pharmaceuticals
Market Cap: CHF 1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 67.90
7D
4.1%
1Y
-2.7%
Newron Pharmaceuticals
Market Cap: CHF 285.0m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 13.82
7D
-2.0%
1Y
61.3%